Last update 28 Jun 2025

LNF-1901

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
LNF 1901, LNF1901
Target
CD40
Action
agonists
Mechanism
CD40 agonists(Tumor necrosis factor receptor superfamily member 5 agonists)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication
Advanced cancer
Originator Organization
Lunan Pharmaceutical Group Co., Ltd.Lunan Pharmaceutical Group Co., Ltd.
Active Organization
Lunan Pharmaceutical Group Co., Ltd.Lunan Pharmaceutical Group Co., Ltd.Shandong New Time Pharmaceutical Co. Ltd.Shandong New Time Pharmaceutical Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with LNF-1901
NCT06226363
/ Not yet recruitingPhase 1
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Initial Efficacy of LNF1901 in Advanced Malignant Tumors
100 Clinical Results associated with LNF-1901
Login to view more data
100 Translational Medicine associated with LNF-1901
Login to view more data
100 Patents (Medical) associated with LNF-1901
Login to view more data
100 Deals associated with LNF-1901
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 1
China
Shandong New Time Pharmaceutical Co. Ltd.Shandong New Time Pharmaceutical Co. Ltd.
01 Mar 2024
NeoplasmsPhase 1-
Shandong New Time Pharmaceutical Co. Ltd.Shandong New Time Pharmaceutical Co. Ltd.
01 Feb 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free